Company / Operating Cash Flow
Xtant Medical Holdings, Inc. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$11.9M
FY2025
5-year range
-$11.9M / $439.0K
FY2021-FY2025
Trend
-25.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has declined for 3 consecutive years, from $439,000 in FY2022 to -$12M in FY2025.
Based on SEC 10-K filings.
-$12M in FY2025.
Declined from -$5M to -$12M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Xtant Medical Holdings, Inc.'s operating cash flow has declined for 3 consecutive years.
- In FY2025, operating cash flow decreased 25.0% year-over-year.
- Peak operating cash flow was recorded in FY2019.
- Lowest operating cash flow in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$11.9M | -25.0% |
| FY2024 | -$9.5M | -78.2% |
| FY2023 | -$5.3M | -1316.6% |
| FY2022 | $439.0K | +160.1% |
| FY2021 | -$731.0K | -77.0% |
| FY2020 | -$413.0K | -134.1% |
| FY2019 | $1.2M | +323.2% |
| FY2018 | -$543.0K | +96.2% |
| FY2017 | -$14.4M | -58.3% |
| FY2016 | -$9.1M | -24.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026